Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Journal of Managed Care & Specialty Pharmacy|May 24, 2017
Value Tools in Managed Care Decision Making: Current Hurdles and Future OpportunitiesJeremy Schafer, Dominic Galante, Jason Shafrin
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|May 17, 2021
When Should You Trust Your Doctor? Establishing a Theoretical Model to Evaluate the Value of Second Opinion VisitsMichael Halasy, Jason Shafrin
Journal of Comparative Effectiveness Research|May 21, 2024
Cost-effectiveness of sotagliflozin for the treatment of patients with diabetes and recent worsening heart failureJaehong Kim, Shanshan Wang, Slaven Sikirica, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 30, 2023
A Decade of Health Innovation: The Impact of New Medicines on Patient Health and the Implications for NICE's Size of Benefit MultiplierJason Shafrin, Sabiha Quddus, Moises Marin, et al.
Managed Care (Langhorne, Pa.)|December 23, 2017
Copayments Not Counting Toward the Deductible Could Have Unintended ConsequencesJeremy Schafer, Ami Gopalan
Journal of Managed Care & Specialty Pharmacy|August 29, 2020
Opportunities and Challenges of Value-Based Health Care: How Brazil Can Learn from U.S. ExperienceCésar Abicalaffe, Jeremy Schafer
Journal of Managed Care & Specialty Pharmacy|March 28, 2025
Economic impact of sotagliflozin among patients with heart failure and type 2 diabetes: Budget impact analysis from the US payer perspectiveJason Shafrin, Shanshan Wang, Jaehong Kim, et al.
Pageof 9